Evaluation and treatment of malignant ascites secondary to gastric cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Evaluation and treatment of malignant ascites secondary to gastric cancer
Authors
Keywords
-
Journal
WORLD JOURNAL OF GASTROENTEROLOGY
Volume 21, Issue 39, Pages 10936
Publisher
Baishideng Publishing Group Inc.
Online
2015-10-23
DOI
10.3748/wjg.v21.i39.10936
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Use of a Pocket-Sized Ultrasound Device Improves Physical Examination: Results of an In- and Outpatient Cohort Study
- (2015) Agostino Colli et al. PLoS One
- Phase II study of trastuzumab in combination with S-1 plus cisplatin in HER2-positive gastric cancer (HERBIS-1)
- (2014) Y Kurokawa et al. BRITISH JOURNAL OF CANCER
- Gastric cancer: ESMO–ESSO–ESTRO clinical practice guidelines for diagnosis, treatment and follow-up
- (2014) T. Waddell et al. EJSO
- Bevacizumab plus capecitabine and cisplatin in Chinese patients with inoperable locally advanced or metastatic gastric or gastroesophageal junction cancer: randomized, double-blind, phase III study (AVATAR study)
- (2014) Lin Shen et al. Gastric Cancer
- Predicting the Amount of Intraperitoneal Fluid Accumulation by Computed Tomography and Its Clinical Use in Patients With Perforated Peptic Ulcer
- (2014) Toru Ishiguro et al. INTERNATIONAL SURGERY
- Anatomy and physiology of the peritoneum
- (2014) Simon C. Blackburn et al. Seminars in Pediatric Surgery
- Clinical Benefit Response in Pancreatic Cancer Trials Revisited
- (2014) Jürg Bernhard et al. Oncology Research and Treatment
- Ascites and malnutrition are predictive factors for incomplete cytoreductive surgery for peritoneal carcinomatosis from gastric cancer
- (2013) Emmanuel I. Benizri et al. AMERICAN JOURNAL OF SURGERY
- Salvage Gastrectomy After Intravenous and Intraperitoneal Paclitaxel (PTX) Administration with Oral S-1 for Peritoneal Dissemination of Advanced Gastric Cancer with Malignant Ascites
- (2013) Joji Kitayama et al. ANNALS OF SURGICAL ONCOLOGY
- Pharmacokinetics of docetaxel in gastric cancer patients with malignant ascites
- (2013) Hidenori Tamegai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials
- (2013) F. Coccolini et al. EJSO
- Results of docetaxel plus oxaliplatin (DOCOX)±cetuximab in patients with metastatic gastric and/or gastroesophageal junction adenocarcinoma: Results of a randomised Phase 2 study
- (2013) Donald Richards et al. EUROPEAN JOURNAL OF CANCER
- Randomized Phase III Study of 5-Fluorouracil Continuous Infusion vs. Sequential Methotrexate and 5-Fluorouracil Therapy in Far Advanced Gastric Cancer with Peritoneal Metastasis (JCOG0106)
- (2013) K. Shirao et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Everolimus for Previously Treated Advanced Gastric Cancer: Results of the Randomized, Double-Blind, Phase III GRANITE-1 Study
- (2013) Atsushi Ohtsu et al. JOURNAL OF CLINICAL ONCOLOGY
- Outcome Measures Other than Morbidity and Mortality for Patients with Incurable Cancer and Gastrointestinal Obstruction
- (2013) Brian Badgwell et al. JOURNAL OF PALLIATIVE MEDICINE
- Epirubicin, oxaliplatin, and capecitabine with or without panitumumab for patients with previously untreated advanced oesophagogastric cancer (REAL3): a randomised, open-label phase 3 trial
- (2013) Tom Waddell et al. LANCET ONCOLOGY
- Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial
- (2013) Florian Lordick et al. LANCET ONCOLOGY
- Clinicopathological characteristics and prognosis of gastric cancer with malignant ascites
- (2013) Nian Fang et al. TUMOR BIOLOGY
- Deterioration in quality of life (QoL) in patients with malignant ascites: results from a phase II/III study comparing paracentesis plus catumaxomab with paracentesis alone
- (2012) P. Wimberger et al. ANNALS OF ONCOLOGY
- Gastric cancer treated in 2002 in Japan: 2009 annual report of the JGCA nationwide registry
- (2012) Atsushi Nashimoto et al. Gastric Cancer
- Malignant ascites: pathophysiology and treatment
- (2012) Emanuel Cavazzoni et al. International Journal of Clinical Oncology
- Multicenter Feasibility Study of Combination Therapy with Fluorouracil, Leucovorin and Paclitaxel (FLTAX) for Peritoneal Disseminated Gastric Cancer with Massive Ascites or Inadequate Oral Intake
- (2012) S. Iwasa et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Assessing clinical benefit response in the treatment of gastric malignant ascites with non-measurable lesions: a multicenter phase II trial of paclitaxel for malignant ascites secondary to advanced/recurrent gastric cancer
- (2011) Haruhiko Imamoto et al. Gastric Cancer
- First-line fluorouracil-based chemotherapy for patients with severe peritoneal disseminated gastric cancer
- (2011) Satoru Iwasa et al. Gastric Cancer
- Japanese gastric cancer treatment guidelines 2010 (ver. 3)
- (2011) Gastric Cancer
- A novel perspective for an orphan problem: Old and new drugs for the medical management of malignant ascites
- (2010) S. Barni et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Weekly paclitaxel for heavily treated advanced or recurrent gastric cancer refractory to fluorouracil, irinotecan, and cisplatin
- (2010) Rai Shimoyama et al. Gastric Cancer
- The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trial
- (2010) Markus M. Heiss et al. INTERNATIONAL JOURNAL OF CANCER
- Systemic chemotherapy for peritoneal disseminated gastric cancer with inadequate oral intake: a retrospective study
- (2010) Satoru Iwasa et al. International Journal of Clinical Oncology
- A Randomized Phase II Trial to Test the Efficacy of Intra-peritoneal Paclitaxel for Gastric Cancer with High Risk for the Peritoneal Metastasis (INPACT Trial)
- (2010) Y. Kodera et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat gastric cancer with ascites and/or peritoneal carcinomatosis: Results from a Chinese center
- (2010) Xiao-Jun Yang et al. JOURNAL OF SURGICAL ONCOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Weekly Intravenous and Intraperitoneal Paclitaxel Combined with S-1 for Malignant Ascites due to Advanced Gastric Cancer
- (2010) Joji Kitayama et al. ONCOLOGY
- Chemotherapy with laparoscope-assisted continuous circulatory hyperthermic intraperitoneal perfusion for malignant ascites
- (2010) Ming-Chen Ba WORLD JOURNAL OF GASTROENTEROLOGY
- Management of ascites due to gastrointestinal malignancy
- (2009) MuhammadW Saif et al. ANNALS OF SAUDI MEDICINE
- Efficacy of sequential methotrexate and 5-fluorouracil (MTX/5FU) in improving oral intake in patients with advanced gastric cancer with severe peritoneal dissemination
- (2009) Masako Imazawa et al. Gastric Cancer
- Paclitaxel chemotherapy for the treatment of gastric cancer
- (2009) Junichi Sakamoto et al. Gastric Cancer
- The clinical significance of ascitic fluid CEA in advanced gastric cancer with ascites
- (2009) Minkyu Jung et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Can the smallest depth of ascitic fluid on sonograms predict the amount of drainable fluid?
- (2009) Abid Irshad et al. JOURNAL OF CLINICAL ULTRASOUND
- Endoscopic ultrasonography-detected low-volume ascites as a predictor of inoperability for oesophagogastric cancer
- (2008) J. Sultan et al. BRITISH JOURNAL OF SURGERY
- Weekly docetaxel monotherapy for advanced gastric or esophagogastric junction cancer
- (2008) K. Abbrederis et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More